TANDEM DIABETES CARE INC

For the period ended Dec 31, 2025. Filed Feb 19, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 19, 2026

TNDM$18.71+3.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of December 31, and

CONSOLIDATED BALANCE SHEETS

(In thousands, except par value)

	December 31,	December 31,
	2025	2024
Assets
Current assets:
Cash and cash equivalents	$90,634	$69,234
Short-term investments	202,032	369,095
Accounts receivable, net	165,491	114,585
Inventories	128,769	149,612
Prepaid and other current assets	31,217	21,965
Total current assets	618,143	724,491
Property and equipment, net	83,580	78,150
Operating lease right-of-use assets	96,172	85,306
Equity method investments	60,351	74,545
Other long-term assets	22,866	5,166
Total assets	$881,112	$967,658
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$47,067	$44,730
Accrued expenses	21,012	18,170
Employee-related liabilities	70,409	64,128
Current portion of convertible senior notes, net	—	40,670
Operating lease liabilities	19,472	18,208
Deferred revenue	9,527	11,831
Other current liabilities	75,237	49,312
Total current liabilities	242,724	247,049
Convertible senior notes, net - long-term	310,036	308,266
Operating lease liabilities - long-term	114,967	106,421
Deferred revenue - long-term	8,474	10,455
Other long-term liabilities	49,741	32,369
Total liabilities	725,942	704,560
Commitments and contingencies (Note 14)	—	—
Stockholders’ equity:
Common stock, $0.001 par value; 200,000 shares authorized, 68,291 and 66,264 shares issued and outstanding as of December 31, 2025 and 2024, respectively	68	66
Additional paid-in capital	1,402,044	1,312,804
Accumulated other comprehensive income (loss)	5,593	(1,947)
Accumulated deficit	(1,252,535)	(1,047,825)
Total stockholders’ equity	155,170	263,098
Total liabilities and stockholders’ equity	$881,112	$967,658

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.